I. - Basic information

I.1 - Surname

Lassanova

I.2 - Name

Monika

I.3 - Degrees

MUDr., PhD., doc.

I.4 - Year of birth

1972

I.5 - Name of the workplace

Institute of Pharmacology and Clinical Pharmacology

I.6 - Address of the workplace

THE DEAN´S OFFICE, Faculty of Medicine Comenius University, Špitálska ulica 24, 813 72 Bratislava

I.7 - Position

Lecturer and Assistant Lecturer

I.8 - E-mail address

monika.lassanova@fmed.uniba.sk

I.9 - Hyperlink to the entry of a person in the Register of university staff

https://www.portalvs.sk/regzam/detail/3262

I.10 - Name of the study field in which a person works at the university

Pharmacology and Clinical Pharmacology

I.11 - ORCID iD

0000-0003-1174-8084

II. - Higher education and further qualification growth

II.1 - First degree of higher education

II.a - Name of the university or institution

Faculty of Medicine Comenius University, Bratislava

II.b - Year

1997

II.c - Study field and programme

General medicine

II.2 - Second degree of higher education

II.a - Name of the university or institution

Faculty of Medicine Comenius University, Bratislava

II.b - Year

1997

II.c - Study field and programme

General medicine

II.3 - Third degree of higher education

II.a - Name of the university or institution

Faculty of Medicine Comenius University, Bratislava

II.b - Year

2008

II.c - Study field and programme

Clinical Pharmacology

II.4 - Associate professor

II.a - Name of the university or institution

Associate Professors

II.b - Year

2024

II.c - Study field and programme

Clinical Pharmacology

II.5 - Professor

II.6 - Doctor of Science (DrSc.)

III. - Current and previous employment

III.a - Occupation-position	III.b - Institution	III.c - Duration
Lecturer	Institute of Pharmacology and Clinical Pharmacology, Faculty of Medicine Comenius University, Bratislava	from August 1997
Assistant Lecturer	Institute of Pharmacology and Clinical Pharmacology, Faculty of Medicine Comenius University, Bratislava	from 2002

IV. - Development of pedagogical, professional, language, digital and other skills

IV.a - Activity description, course name, other	IV.b - Name of the institution	IV.c - Year
Internship in the UK, Perscription Event monitoring pharmacovigilance system	Drug Safety Research Unit (DSRU), Southampton, UK	1999
Specialization I. degree in Internal Medicine	SLOVAK MEDICAL UNIVERSITY IN BRATISLAVA (SZU)	2001
Thematic course in social medicine and health care organization	SLOVAK MEDICAL UNIVERSITY IN BRATISLAVA (SZU)	2006
Training post in clinical pharmacology before the specialization examination	SLOVAK MEDICAL UNIVERSITY IN BRATISLAVA (SZU)	2006
Specialization II. degree in Clinical Pharmacology	SLOVAK MEDICAL UNIVERSITY IN BRATISLAVA (SZU)	2006
Expert consultant	GENAS Association for Generic and Biosimilars Medicines	from 2005
SIM2 course - Simulation in Medicine - Debriefing	New York University School of Medicine and Faculty of Medicine, Comenius University in Bratislava	2018
Member of the Committee on Safety of Medicines	State Institute for Drug Control (ŠÚKL)	from 2022
Scientific - qualification degree IIa	Slovak Academy of Sciences	2022
Medical Education Basics and Elearning course Course Development in Moodle	Institute of Medical Education and Simulations LFUK	2024

V. - Overview of activities within the teaching career at the university

V.1 - Overview of the profile courses taught in the current academic year according to study programmes

V.1.a - Name of the profile course	V.1.b - Study programme	V.1.c - Degree	V.1.d - Field of study
Pharmacology 1 and 2, Slovak and English language	General medicine	II.	General medicine
Pharmacology 1 and 2, Slovak and English language	Dentistri	II.	Dentistri
NEW DRUGS AND STRATEGIES IN PHARMACOTHERAPY	All PH.D. study programs at the Comenius University	III.	ll related departments (Faculties) at the Comenius University
Member of the PH.D. union committee studies at the Faculty of Pharmacy, Comenius University	Faculty of Pharmacy, Comenius Universit	III.	Pharmacology
Member of the State Commission at the Faculty of Medicine, Comenius University	Gynaecology and Obstetrics	II-	2024
Member of the State Commission for the defense of diploma thesesat the Faculty of Medicine, Comenius University	Pharmacology	II.	2019

V.2 - Overview of the responsibility for the delivery, development and quality assurance of the study programme or its part at the university in the current academic year

V.3 - Overview of the responsibility for the development and quality of the field of habilitation procedure and inaugural procedure in the current academic year

V.4 - Overview of supervised final theses

V.4.1 - Number of currently supervised theses

V.4.b - Diploma (second degree)

V.4.2 - Number of defended theses

V.4.b - Diploma (second degree)

V.5 - Overview of other courses taught in the current academic year according to study programmes

V.5.a - Name of the course	V.5.b - Study programme	V.5.c - Degree	V.5.d - Field of study
Compulsory optional subject Clinical pharmacology in English and Slovak language	General medicine	II.	General medicine
Compulsory optional subject Clinical pharmacology in English and Slovak language	Dentistry	II.	Dentistry

VI. - Overview of the research/artistic/other outputs

VI.1 - Overview of the research/artistic/other outputs and the corresponding citations

VI.1.1 - Number of the research/artistic/other outputs

VI.1.a - Overall

318

VI.1.b - Over the last six years

VI.1.2 - Number of the research/artistic/other outputs registered in the Web of Science or Scopus databases

VI.1.a - Overall

Web of Science - 17 / Scopus databases - 43

VI.1.b - Over the last six years

Web of Science - 4 / Scopus databases - 10

VI.1.3 - Number of citations corresponding to the research/artistic/other outputs

VI.1.a - Overall

160

VI.1.b - Over the last six years

VI.1.4 - Number of citations registered in the Web of Science or Scopus databases

VI.1.5 - Number of invited lectures at the international, national level

VI.1.a - Overall

VI.2 - The most significant research/artistic/other outputs

Laššánová M, Laššán Š, Líšková S, Tesař T, Čičová M: Analysis of spontaneous reports of

suspected adverse reactions after vaccination against COVID-19 in Slovakia. Frontiers in

Pharmacology. 2023;14:1-8, art. no. 1097890. ISSN1663-9812. (IF = 5.6; Q1)

Laššán Š, Tesař T, Tisoňová J, Laššánová M: Pharmacological approaches to pulmonary

fibrosis following COVID-19. Frontiers in Pharmacology. 2023;14:1-13. ISSN 1663-9812 . (IF =

5,6; Q1)

Laššán Š, Gočová M, Solovič I, Tesař T, Motešická Z, Laššánová M: Nirmatrelvir/ritonavir and

pharmacovigilance data. The international journal of tuberculosis and lung disease

[elektronický dokument]. 2024;28(2):41-43. ISSN 1027-3719. (IF = 4,0; Q2)

Ježová D, Dunčko R, Laššánová M, Kriška M, Monček, F: Reduction of rise in blood pressure

and cortisol release during stress by ginkgo biloba extracts (EGB 761) in healthy volunteers.

Journal of Physiology and Pharmacology. 2002;53(3): 337-348. ISSN 0867-5910. (IF = 1,406;

Q3)

Wilton LV, Kollárová Laššánová M, Heeley E, Shakir A: Relative risk of vaginal candidiasis

after use of antibiotics compared with antidepressants in women - Postmarketing surveillance

data in England. Drug Safety. 2003;26(8):589-597. ISSN 0114-5916. (IF = 2,971; Q1)

VI.3 - The most significant research/artistic/other outputs over the last six years

Laššánová M, Laššán Š, Líšková S, Tesař T, Čičová M: Analysis of spontaneous reports of

suspected adverse reactions after vaccination against COVID-19 in Slovakia. Frontiers in

Pharmacology. 2023;14:1-8, art. no. 1097890. ISSN1663-9812. (IF = 5.6; Q1)

Laššán Š, Tesař T, Tisoňová J, Laššánová M: Pharmacological approaches to pulmonary

fibrosis following COVID-19. Frontiers in Pharmacology. 2023;14:1-13. ISSN 1663-9812 . (IF =

5,6; Q1)

Laššán Š, Gočová M, Solovič I, Tesař T, Motešická Z, Laššánová M: Nirmatrelvir/ritonavir and

pharmacovigilance data. The international journal of tuberculosis and lung disease

[elektronický dokument]. 2024;28(2):41-43. ISSN 1027-3719. (IF = 4,0; Q2)

Laššánová M, Líšková S, Tisoňová J, Fundarková S, Laššán Š: Biopharmaceuticals safety

perception in Slovakia: considerations and real-life pharmacovigilance data. Bratislava medical

journal. 2021;122(7): 443-448. ISSN 0006-9248. (IF = 1,564; Q4)

Laššán Š, Keszegh J, Laššánová M: Characteristics of COPD patients treated with singleinhaler

triple therapy in real-life clinical practice. Bratislava medical journal. 2022;123(1):27-

36. ISSN 0006-9248. (IF = 1,564; Q4)

Petrova M, Lassanova M, Tisonova J, Liskova S. Ca²⁺-Dependent Cl^- Channels in Vascular Tone Regulation during Aging. Int J Mol Sci. 2024 May 7;25(10):5093. doi: 10.3390/ijms25105093. (IF = 4,9)

VI.4 - The most significant citations corresponding to the research/artistic/other outputs

Sobel JD: Vulvovaginal candidosis. Lancet, 2007;369(9577):1961-1971

Hu ZP, Yang XX, Ho PCl, et al: Herb-drug interactions: a literature review. Drugs,

2005;65(9):1239-1282

Nausch B, Bittner CB, Höller M, et al: Contribution of Symptomatic, Herbal Treatment Options

to Antibiotic Stewardship and Microbiotic Health. Antibiotics, 2022;11(10):1331

Barkhordar M, Chahardouli B, Biglari A, et al: Three doses of arecombinant conjugated SARSCoV-

2 vaccine early after allogeneic hematopoietic stem cell transplantation: predicting

indicators of a high serologic response-a prospective, single-arm study. Frontiers in

Immunology, 2023;14:1169666

Johnston J, Dorrian D, Linden D, et al: Pulmonary Sequelae of COVID-19: Focus on Interstitial

Lung Disease. Cells, 2023;12(18):2238

VI.5 - Participation in conducting (leading) the most important research projects or art projects over the last six years

VEGA 2/0093/08: Perception of the risk of medicines - a key factor in their utilization. Solution period project: 1.1.2008 – 31.12.2011. Responsible researcher: Prof. Milan Kriška, DrSc., Medicine faculty of the University of Bratislava, 2007:8p. Co-investigator.

VEGA 1/0135/09: Peculiarities of pharmacotherapy in geriatrics and possibilities for evaluating its quality. Project implementation period: 1.1.2009 – 31.12.2012. Responsible researcher: Prof. MUDr. Martin Wawruch PhD., Faculty of Medicine UK Bratislava, 2012:13p. Co-investigator.

KEGA – 038UK-4/2018: Integration of model situations into the teaching of general pharmacology with the implementation of the iSTAN simulator in pharmacokinetic and pharmacodynamics characteristics of drugs. Project implementation period: 1.1.2008 – 31.12.2011. Responsible solver: Doc. PharmDr. Andrea Gažová, PhD., Faculty of Medicine, University of Bratislava. Co-investigator.

EU project, from the SR-AT cross-border cooperation program, Interreg V-A: "Nutrition and health aging" - NUTRIAGING (http://www.nutriaging.eu/). Project solution period: 1.9.2019 – 31.8.2022. Chief project manager: Prof. RNDr. Jana Muchová, PhD., Faculty of Medicine, Charles University Bratislava. Co-investigator.

Kód projektu ITMS 2014+: 3130001692. Kód výzvy: IP_ZS2_123_0027. Číslo ŽoIP: ZoIP_ZS2_123_0027. Operačný program Integrovaná infraštruktúra. Názov: Podpora manažmentu pacienta s chronickým ochorením dýchacích ciest s obštrukciou s cieľom zníženia záťaže poskytovateľov vo forme neplánovanej zdravotnej starostlivosti, zlepšenie pacientských ukazovateľov a zdravotno-sociálnych dopadov ochorení, zvýšenie efektivity vynakladania verejných zdrojov. Vykonávateľ: Slovenská inovačná a energetická agentúra. Bratislava.

Obdobie riešenia projektu: rok 2023. Garantka a riešiteľka.

VII. - Overview of organizational experience related to higher education and research/artistic/other activities

VII.a - Activity, position	VII.b - Name of the institution, board	VII.c - Duration
Co-organizer and responsible person for the courses "Communication at drug risk"	Institute of Pharmacology and Clinical Pharmacology	2006 - 2008
Main co-organizer "HTA International Conference - SLS"	Slovak Society of Health Technologies Assessment (HTA) SLS o. z.	from 2021 until now
Responsible for the organization and the activity of "Drug Information center"	Institute of Pharmacology and Clinical Pharmacology	1998 - 2008
Member of the Security Commission of medicines of the State Institute for Control medicines	State Institute for Control medicines (ŠÚKL)	from 2022 until now, from 2024 - vice-chairman

VIII. - Overview of international mobilities and visits oriented on education and research/artistic/other activities in the given field of study

VIII.a - Name of the institution	VIII.b - Address of the institution	VIII.c - Duration (indicate the duration of stay)	VIII.d - Mobility scheme, employment contract, other (describe)
Drug Safety Research Unit (DSRU)	Bursledon Hall, Blundell Ln, Bursledon, Southampton SO31 1AA, UK	1999 - one month	Contact person: Prof., Dr. R. Mann (the director at the time)

IX. - Other relevant facts

IX.a - If relevant, other activities related to higher education or research/artistic/other activities are mentioned

Since 2006 - Reviews for journals Clinical Pharmacology and Pharmacy, Via practica, Internal Medicine, Practical Pharmacy

Since 2015 - Member of the editorial board of the journal New Medicines

2016 - Prize of the Literary Fund of the Slovak Republic, section for Scientific and Professional Literature for the year 2016, in

Biomedical Sciences category - for the work "Epilepsy and woman " (M. Laššánová, R. Sysák, P. Šiarnik, B. Kollár)

From 2018 - till now: Member of the trade union committee Member of the PH.D. committee at the Faculty of Pharmacy Comenius University, in the field of Pharmacology

Since 2019 - opponent of VEGA and KEGA grants

Since 2019 - founding member and committee member Slovak Society of Health Technology Assessment (HTA) SLS

Since 2025 - member of the presidency of Slovak Pharmacological Society SLS

From 2020 - founding member, member of the Executive Committee Member of the Board of the o.z. Dogs for Life (breeding and training of guide dogs)

2022 - awarded Scientific - qualification degree IIa, Slovak Academy of Sciences

Since 2023 - Member of the Expert Group for Education o.z. Rodicia.sk

Date of last update

2025-01-27

Name and surname:	doc. MUDr. Monika Laššánová, PhD.
Document type:	Research/art/teacher profile of a person
The name of the university:	Comenius University Bratislava
The seat of the university:	Šafárikovo námestie 6, 818 06 Bratislava